⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14878022 | 0.67 | — | — | |
| Hno SCHEMBL28133861 | 0.60 | — | — | |
| SCHEMBL22636 | 0.59 | — | — | |
| SCHEMBL15166545 | 0.59 | — | — | |
| SCHEMBL5080727 | 0.59 | — | — | |
| SCHEMBL17836978 | 0.56 | — | — | |
| SCHEMBL8480708 | 0.56 | — | — | |
| SCHEMBL91335 | 0.56 | — | — | |
| SCHEMBL1068529 | 0.56 | — | — | |
| SCHEMBL13965289 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 426 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2988732-A1 | MODIFIED HYDROGELS | Ascendis Pharma A/S (DK) | 2016-03-02 | — | — | EP | claimed |
| WO-2014173762-A1 | MODIFIED HYDROGELS | ASCENDIS PHARMA A/S (DK) | 2014-10-30 | — | — | WO | claimed |
| EP-0582823-B1 | Slow-releasing resin moldings and process for producing the same | SUMITOMO CHEMICAL CO (JP) | 1999-01-07 | — | — | EP | claimed |
| US-5476652-A | Porous body obtained by stretching thermoplastic resin | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-12-19 | — | — | US | claimed |
| EP-0582823-A1 | Slow-releasing resin moldings and process for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1994-02-16 | — | — | EP | claimed |
| EP-2713736-B1 | NOVEL IMMUNE SYSTEM MODULATORS | JANUS BIOTHERAPEUTICS INC (US) | 2023-08-02 | — | — | EP | disclosed |
| US-20190328840-A1 | CONTROLLED-RELEASE CNP AGONISTS WITH LOW INITIAL NPR-B ACTIVITY | ASCENDIS PHARMA GROWTH DISORDERS A/S (DK) | 2019-10-31 | — | — | US | disclosed |
| US-20190008977-A1 | CNP PRODRUGS WITH CARRIER ATTACHMENT AT THE RING MOIETY | ASCENDIS PHARMA GROWTH DISORDERS A/S (DK) | 2019-01-10 | — | — | US | disclosed |
| US-9861707-B2 | Treating bladder tumor cells using fibronectin attachment protein as a target | PURDUE RESEARCH FOUNDATION (US) | 2018-01-09 | — | — | US | disclosed |
| EP-2758339-B1 | INTEGRATED CHEMICAL LOOPING AIR SEPARATION IN LARGE-SCALE OXY-FUEL PLANTS | NEWCASTLE INNOVATION LTD (AU) | 2017-12-20 | — | — | EP | disclosed |
| US-9847329-B2 | Structure of fin feature and method of making same | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2017-12-19 | — | — | US | disclosed |
| US-9822353-B2 | PEGylated aspartyl-tRNA synthetase polypeptides | ATYR PHARMA, INC. (US) | 2017-11-21 | — | — | US | disclosed |
| EP-0966884-A2 | Pest repellent compositions | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-12-29 | — | — | EP | disclosed |
| WO-1999065897-A1 | INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 | CHIRON CORPORATION (US) | 1999-12-23 | — | — | WO | disclosed |
| WO-1999058013-A1 | RE-FORMATION OF KERATINOUS FIBRE CROSS LINKS | NOVO NORDISK A/S (DK) | 1999-11-18 | — | — | WO | disclosed |
| US-5899212-A | CLEAVAGE OF DISULFIDE BONDS, OXIDOREDUCTASE | NOVO NORDISK A/S (DK) | 1999-05-04 | — | — | US | disclosed |
| EP-0582823-B1 | Slow-releasing resin moldings and process for producing the same | SUMITOMO CHEMICAL CO (JP) | 1999-01-07 | — | — | EP | disclosed |
| EP-0858063-A1 | INDICATOR | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1998-08-12 | — | — | EP | disclosed |
| US-5476652-A | Porous body obtained by stretching thermoplastic resin | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-12-19 | — | — | US | disclosed |
| EP-0582823-A1 | Slow-releasing resin moldings and process for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1994-02-16 | — | — | EP | disclosed |